Analysis leads to FDA RMAT submission and late-breaking abstract for implantable cell therapy - NEWARK, Del., Aug. 7, 2025 ...

If you have a health condition affecting your stomach, such as Coeliac disease, Crohn’s disease or ulcerative colitis, it may ...

The Department for Work and Pensions (DWP) is set to issue £187 weekly payments if you have stomach problems. Personal ...

A new Crohn’s treatment that involves guselkumab showed outstandingly greater rates of endoscopic improvement, which are vital for reducing long-term complications.

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. It can have a very severe impact on ...

FDA approves guselkumab for Crohn's disease treatment after trials show better remission and healing than standard biologics like ustekinumab.

On Sunday, she hosted the 4th annual Crohn’s and Colitis car show and fundraiser at the farm by the beer tree. Sisson has been around cars her entire life, in particular thanks to her late ...

In this video, Joseph M. Runde, DO, attending physician in gastroenterology, hepatology and nutrition at Ann & Robert H. Lurie Children’s Hospital of Chicago and assistant professor ...

More than 36,300 people are claiming PIP or ADP for gastrointestinal conditions including Crohn’s, Colitis and Coeliac disease.

Eli Lilly Canada Inc. (Lilly Canada) announced today that Health Canada has approved Omvoh® (mirikizumab) for CD, which will soon be available to patients in Canada. Omvoh® is an interleukin ...

TDM in Crohn’s: Proactive vs Reactive Use Dr Adam Cheifetz discusses therapeutic drug monitoring strategies for Crohn’s disease.

A successful claim for Personal Independence Payment (PIP) can provide between £29.20 and £187.45 each week in extra ...